Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-30, Stock:JNJ, The news for the past five days is as follows:
2020-11-20: NEWS1: U.S. sees spike in daily COVID-19 cases, hospitalizations surge.NEWS2: 7 Hot Stocks to Buy Before 2021 Ushers in Change.NEWS3: Moderna, Pfizer having similar efficacies is ‘quite encouraging’: Doctor on vaccine progress.NEWS4: WHO advises against using Remdesivir to treat COVID-19.NEWS5: Johnson & Johnson ordered to pay $120 million damages in New York baby powder case.NEWS6: Is Johnson & Johnson (JNJ) a Suitable Pick for Value Investors?.NEWS7: Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More.NEWS8: Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday.NEWS9: Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna.NEWS10: Coronavirus update: Pfizer/BioNTech file for emergency vaccine use as WHO hits Gilead's remdesivir.
2020-11-23: NEWS1: Psychedelic Drug Stock's Biggest Investor Closes $125 Million Funding Round.NEWS2: 3 Dividend Stocks to Buy on Sale.NEWS3: Coronavirus update: FDA OKs Regeneron antibody EUA; AstraZeneca shows positive vaccine results.NEWS4: AstraZeneca vaccine is ‘highly suitable for people in the U.S. & Europe’: AstraZeneca exec.NEWS5: 10 Best Selling Products Online in 2020.NEWS6: Q&A: Where are we in the COVID-19 vaccine race?.NEWS7: Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By February.
2020-11-24: NEWS1: Merck Sales Hit Hardest by Pandemic.NEWS2: Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU.NEWS3: 'Reflationary trends' are going to continue into 2021: Research Affiliates.NEWS4: EU strikes deal with Moderna to supply up to 160 million COVID vaccine shots.NEWS5: Pennant Investors Exits Johnson & Johnson, Cuts Amazon.NEWS6: How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?.NEWS7: Coronavirus vaccine: AstraZeneca could expand US trial to pursue 90% efficacious vaccine.
2020-11-25: NEWS1: Overlook Novavax at the Risk of Incurring an Opportunity Cost.NEWS2: COVID-19 is the ‘silent pandemic’, this surge is not like last spring: Robert Redfield.NEWS3: 3 Stocks to Help You Build Retirement Wealth.NEWS4: What Does Johnson & Johnson's Debt Look Like?.
2020-11-27: NEWS1: Peru secures 23.1 million future coronavirus vaccine doses from Pfizer, COVAX.NEWS2: Stock market news live updates: Wall Street notches slim gains; Nasdaq, S&P 500 set new records.NEWS3: Here's How Much Investing $1,000 In Major Coronavirus Vaccine Developers Before Their Announcements Would Fetch.NEWS4: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.

Answer: Rise